← Open Payments lookup

REBECCA EZELL: Open Payments

NPI 1205333622 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$154,094 in 417 payments from 22 companies in 2025. Trend: 2023 $38,354 · 2024 $63,099 · 2025 $154,094

Speaker / faculty: $113,223Travel & lodging: $25,836Food & beverage: $9,211Consulting: $5,790Education: $34
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP197$85,945
Regeneron Healthcare Solutions, Inc.80$33,398
GENZYME CORPORATION51$27,551
GlaxoSmithKline, LLC.38$4,507
Regeneron Pharmaceuticals, Inc.2$1,392
Grifols USA, LLC8$326
Boehringer Ingelheim Pharmaceuticals, Inc.2$147
United Therapeutics Corporation6$142
Inspire Medical Systems, Inc.2$103
Electromed, Inc.11$93

Products named: DUPIXENT, AIRSUPRA, FASENRA, BREZTRI, NUCALA, Prolastin-C Liquid, TEZSPIRE, TRELEGY ELLIPTA.

Industry payments across LA — which companies pay providers there.